Next Article in Journal
Novel Uridine Glycoconjugates, Derivatives of 4-Aminophenyl 1-Thioglycosides, as Potential Antiviral Compounds
Previous Article in Journal
Correlation of FT-IR Fingerprint and α-Glucosidase Inhibitory Activity of Salak (Salacca zalacca) Fruit Extracts Utilizing Orthogonal Partial Least Square
Previous Article in Special Issue
Assessing Photosensitizer Targeting Using Meso-Tetra(Carboxyphenyl) Porphyrin
Article Menu
Issue 6 (June) cover image

Export Article

Open AccessArticle
Molecules 2018, 23(6), 1436; https://doi.org/10.3390/molecules23061436

Synthesis and Evaluation of New Potential Benzo[a]phenoxazinium Photosensitizers for Anticancer Photodynamic Therapy

1
School of Biological Science and Technology, University of Jinan, Jinan 250022, China
2
Faculty of Ceilandia, University of Brasília, Brasilia 72220275, Brazil
3
Institute of Biological Sciences, University of Brasília, Brasilia 70910900, Brazil
*
Authors to whom correspondence should be addressed.
Received: 16 May 2018 / Revised: 31 May 2018 / Accepted: 8 June 2018 / Published: 13 June 2018
(This article belongs to the Special Issue Advances in Photodynamic Therapy 2018)
View Full-Text   |   Download PDF [2239 KB, uploaded 13 June 2018]   |  

Abstract

The use of photodynamic therapy (PDT) and development of novel photosensitizers (PSs) for cancer treatment have received more and more attention nowadays. In the present work, five benzo[a]phenoxazinium derivatives have been prepared and evaluated for their in vitro anticancer photodynamic activity for the first time. They are red light absorbers and show low fluorescence quantum yield. Of these compounds, PS4 exhibited a higher quantum yield for reactive oxygen species (ROS) generation. The assays with cells in vitro showed that PS1 and PS4 were not significantly toxic in the dark, but was robustly toxic against the murine breast adenocarcinoma cells 4T1 and normal murine fibroblast cells NIH-3T3 upon photoactivation. More interestingly, PS5 was particularly selective towards 4T1 cancer cells and nearly non-phototoxic to non-cancerous NIH-3T3 cells. The results described in this report suggest that these new benzo[a]phenoxazinium derivatives are potential candidates as PSs for anticancer PDT. Further investigation of benzo[a]phenoxaziniums for anticancer PDT is warranted. View Full-Text
Keywords: benzo[a]phenoxazinium; photosensitizer; reactive oxygen species; photodynamic therapy; anticancer benzo[a]phenoxazinium; photosensitizer; reactive oxygen species; photodynamic therapy; anticancer
Figures

Graphical abstract

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Supplementary material

SciFeed

Share & Cite This Article

MDPI and ACS Style

Zhang, J.; Tavares de Sousa Júnior, W.; Mello da Silva, V.C.; Rodrigues, M.C.; Vasconcelos Morais, J.A.; Song, J.-L.; Cheng, Z.-Q.; Longo, J.P.F.; Bentes Azevedo, R.; Jiang, C.-S.; Alexandre Muehlmann, L.; Zhang, H. Synthesis and Evaluation of New Potential Benzo[a]phenoxazinium Photosensitizers for Anticancer Photodynamic Therapy. Molecules 2018, 23, 1436.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top